NanoVibronix Net Income vs Begin Period Cash Flow Analysis

NAOV Stock  USD 0.60  0.0001  0.02%   
NanoVibronix financial indicator trend analysis is infinitely more than just investigating NanoVibronix recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NanoVibronix is a good investment. Please check the relationship between NanoVibronix Net Income and its Begin Period Cash Flow accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoVibronix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy NanoVibronix Stock please use our How to Invest in NanoVibronix guide.

Net Income vs Begin Period Cash Flow

Net Income vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NanoVibronix Net Income account and Begin Period Cash Flow. At this time, the significance of the direction appears to have pay attention.
The correlation between NanoVibronix's Net Income and Begin Period Cash Flow is -0.72. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of NanoVibronix, assuming nothing else is changed. The correlation between historical values of NanoVibronix's Net Income and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of NanoVibronix are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Net Income i.e., NanoVibronix's Net Income and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.72
Relationship DirectionNegative 
Relationship StrengthWeak

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in NanoVibronix financial statement analysis. It represents the amount of money remaining after all of NanoVibronix operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Most indicators from NanoVibronix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NanoVibronix current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoVibronix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy NanoVibronix Stock please use our How to Invest in NanoVibronix guide.At this time, NanoVibronix's Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to climb to 0.39 in 2024, whereas Selling General Administrative is likely to drop slightly above 2.4 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit770K167K1.5M1.6M
Total Revenue1.7M752K2.3M2.4M

NanoVibronix fundamental ratios Correlations

-0.530.830.240.830.42-0.9-0.790.430.95-0.11-0.230.950.52-0.410.66-0.170.610.860.140.221.0-0.20.40.090.01
-0.53-0.40.55-0.78-0.010.780.58-0.45-0.50.570.57-0.5-0.4-0.07-0.450.03-0.34-0.620.540.05-0.550.73-0.33-0.16-0.47
0.83-0.40.440.660.36-0.68-0.880.380.69-0.03-0.140.690.71-0.590.85-0.180.590.790.340.170.82-0.080.730.12-0.15
0.240.550.44-0.190.180.12-0.220.130.150.760.680.150.15-0.320.22-0.230.220.170.840.080.210.70.20.07-0.29
0.83-0.780.66-0.190.26-0.9-0.810.410.79-0.4-0.470.790.67-0.220.74-0.380.380.82-0.390.20.84-0.520.52-0.210.02
0.42-0.010.360.180.26-0.24-0.3-0.360.33-0.09-0.280.33-0.05-0.590.32-0.020.640.390.160.920.43-0.070.19-0.11-0.49
-0.90.78-0.680.12-0.9-0.240.7-0.48-0.930.310.39-0.93-0.470.21-0.550.05-0.51-0.760.14-0.05-0.910.45-0.27-0.19-0.28
-0.790.58-0.88-0.22-0.81-0.30.7-0.48-0.610.130.21-0.61-0.830.34-0.940.49-0.49-0.940.05-0.24-0.780.21-0.790.160.09
0.43-0.450.380.130.41-0.36-0.48-0.480.40.250.290.40.350.450.25-0.280.190.5-0.04-0.460.410.070.160.10.61
0.95-0.50.690.150.790.33-0.93-0.610.4-0.1-0.211.00.39-0.320.47-0.030.520.690.120.110.95-0.210.150.190.12
-0.110.57-0.030.76-0.4-0.090.310.130.25-0.10.98-0.1-0.210.2-0.19-0.27-0.06-0.150.57-0.07-0.150.67-0.210.030.05
-0.230.57-0.140.68-0.47-0.280.390.210.29-0.210.98-0.21-0.210.33-0.27-0.27-0.21-0.240.5-0.24-0.260.66-0.240.030.14
0.95-0.50.690.150.790.33-0.93-0.610.41.0-0.1-0.210.39-0.320.47-0.030.520.690.120.110.95-0.210.150.190.12
0.52-0.40.710.150.67-0.05-0.47-0.830.350.39-0.21-0.210.39-0.360.9-0.530.010.66-0.13-0.020.52-0.160.81-0.33-0.28
-0.41-0.07-0.59-0.32-0.22-0.590.210.340.45-0.320.20.33-0.32-0.36-0.53-0.18-0.25-0.26-0.42-0.47-0.420.07-0.48-0.090.68
0.66-0.450.850.220.740.32-0.55-0.940.250.47-0.19-0.270.470.9-0.53-0.50.30.81-0.050.320.66-0.190.91-0.28-0.36
-0.170.03-0.18-0.23-0.38-0.020.050.49-0.28-0.03-0.27-0.27-0.03-0.53-0.18-0.50.11-0.430.34-0.24-0.16-0.04-0.470.80.29
0.61-0.340.590.220.380.64-0.51-0.490.190.52-0.06-0.210.520.01-0.250.30.110.580.280.380.61-0.140.20.30.14
0.86-0.620.790.170.820.39-0.76-0.940.50.69-0.15-0.240.690.66-0.260.81-0.430.58-0.080.310.86-0.250.61-0.120.0
0.140.540.340.84-0.390.160.140.05-0.040.120.570.50.12-0.13-0.42-0.050.340.28-0.08-0.060.110.64-0.050.52-0.12
0.220.050.170.080.20.92-0.05-0.24-0.460.11-0.07-0.240.11-0.02-0.470.32-0.240.380.31-0.060.23-0.050.23-0.37-0.61
1.0-0.550.820.210.840.43-0.91-0.780.410.95-0.15-0.260.950.52-0.420.66-0.160.610.860.110.23-0.230.40.090.01
-0.20.73-0.080.7-0.52-0.070.450.210.07-0.210.670.66-0.21-0.160.07-0.19-0.04-0.14-0.250.64-0.05-0.23-0.160.04-0.15
0.4-0.330.730.20.520.19-0.27-0.790.160.15-0.21-0.240.150.81-0.480.91-0.470.20.61-0.050.230.4-0.16-0.31-0.38
0.09-0.160.120.07-0.21-0.11-0.190.160.10.190.030.030.19-0.33-0.09-0.280.80.3-0.120.52-0.370.090.04-0.310.58
0.01-0.47-0.15-0.290.02-0.49-0.280.090.610.120.050.140.12-0.280.68-0.360.290.140.0-0.12-0.610.01-0.15-0.380.58
Click cells to compare fundamentals

NanoVibronix Account Relationship Matchups

NanoVibronix fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.0M8.2M8.6M5.9M6.7M3.7M
Other Current Liab280K2.5M1.7M2.1M2.3M2.4M
Total Current Liabilities409K2.9M1.9M2.3M2.5M1.8M
Total Stockholder Equity1.3M2.4M6.3M3.2M4.0M4.2M
Property Plant And Equipment Net4K35K54K88K12K11.4K
Net Debt(1.3M)(7.1M)(7.7M)(2.6M)(3.3M)(3.1M)
Retained Earnings(38.3M)(42.7M)(56.9M)(62.4M)(66.1M)(62.8M)
Accounts Payable129K144K87K66K138K103.5K
Cash1.3M7.1M7.7M2.7M3.3M2.6M
Non Current Assets Total198K259K280K270K187K228.2K
Non Currrent Assets Other194K200K207K179K175K205.1K
Cash And Short Term Investments1.3M7.1M7.7M2.7M3.3M2.6M
Net Receivables130K93K264K109K425K446.3K
Common Stock Shares Outstanding347.0K514.9K1.3M1.4M1.8M1.8M
Liabilities And Stockholders Equity2.0M8.2M8.6M5.9M6.7M3.7M
Non Current Liabilities Total279K2.9M406K330K232K220.4K
Other Current Assets249K590K166K612K47K44.7K
Other Stockholder Equity39.7M45.0M63.2M65.6M70.1M36.5M
Total Liab688K5.8M2.3M2.6M2.7M2.2M
Property Plant And Equipment Gross4K4.054K88K12K11.4K
Total Current Assets1.8M8.0M8.3M5.6M6.5M3.3M
Accumulated Other Comprehensive Income(54K)66K60K(18K)(67K)(70.4K)
Inventory121K145K175K2.2M2.7M2.9M
Other Liab279K2.9M406K330K297K282.2K
Other Assets194K255.0208K179K161.1K216.3K
Net Tangible Assets1.3M2.4M6.3M3.2M3.7M3.9M
Capital Surpluse32.0M33.0M39.7M45.0M51.7M31.5M
Retained Earnings Total Equity(28.4M)(32.6M)(38.3M)(42.7M)(38.4M)(40.3M)
Non Current Liabilities Other434K477K279K462K415.8K796.7K
Net Invested Capital1.3M2.4M6.3M3.2M4.0M3.4M
Net Working Capital1.4M5.1M6.4M3.3M4.0M3.9M
Capital Stock9K24K28K2K1.8K1.7K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NanoVibronix Stock Analysis

When running NanoVibronix's price analysis, check to measure NanoVibronix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoVibronix is operating at the current time. Most of NanoVibronix's value examination focuses on studying past and present price action to predict the probability of NanoVibronix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoVibronix's price. Additionally, you may evaluate how the addition of NanoVibronix to your portfolios can decrease your overall portfolio volatility.